CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 1 filers reported holding CONCERT PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,340 | -99.9% | 571,990 | +26.3% | 0.00% | -66.7% |
| Q3 2022 | $3,033,000 | +90.9% | 452,754 | +20.0% | 0.00% | +200.0% |
| Q2 2022 | $1,589,000 | +981.0% | 377,413 | +764.6% | 0.00% | – |
| Q1 2022 | $147,000 | -46.7% | 43,654 | -50.0% | 0.00% | – |
| Q4 2021 | $276,000 | +76.9% | 87,308 | +83.9% | 0.00% | – |
| Q3 2021 | $156,000 | -21.2% | 47,480 | +0.9% | 0.00% | – |
| Q2 2021 | $198,000 | -41.9% | 47,035 | -31.2% | 0.00% | – |
| Q1 2021 | $341,000 | -49.9% | 68,400 | +27.2% | 0.00% | – |
| Q4 2020 | $680,000 | +248.7% | 53,758 | +171.1% | 0.00% | – |
| Q3 2020 | $195,000 | +25.0% | 19,833 | +26.0% | 0.00% | – |
| Q2 2020 | $156,000 | +105.3% | 15,745 | +80.9% | 0.00% | – |
| Q1 2020 | $76,000 | -62.7% | 8,702 | -60.6% | 0.00% | – |
| Q4 2019 | $204,000 | +204.5% | 22,107 | +93.0% | 0.00% | – |
| Q3 2019 | $67,000 | -85.3% | 11,454 | -69.8% | 0.00% | – |
| Q2 2019 | $455,000 | -76.7% | 37,885 | -76.6% | 0.00% | -100.0% |
| Q1 2019 | $1,954,000 | +7716.0% | 161,834 | +8328.9% | 0.00% | – |
| Q4 2018 | $25,000 | -91.6% | 1,920 | -90.4% | 0.00% | – |
| Q3 2018 | $297,000 | +130.2% | 19,950 | +161.9% | 0.00% | – |
| Q2 2018 | $129,000 | -31.7% | 7,616 | -7.8% | 0.00% | – |
| Q1 2018 | $189,000 | -64.6% | 8,263 | -60.0% | 0.00% | – |
| Q4 2017 | $534,000 | +352.5% | 20,682 | +159.1% | 0.00% | – |
| Q3 2017 | $118,000 | +2850.0% | 7,982 | +2483.2% | 0.00% | – |
| Q2 2017 | $4,000 | -94.9% | 309 | -93.2% | 0.00% | – |
| Q1 2017 | $78,000 | +69.6% | 4,547 | +1.5% | 0.00% | – |
| Q4 2016 | $46,000 | +1433.3% | 4,482 | +1313.9% | 0.00% | – |
| Q3 2016 | $3,000 | -25.0% | 317 | -13.2% | 0.00% | – |
| Q2 2016 | $4,000 | +300.0% | 365 | +172.4% | 0.00% | – |
| Q1 2016 | $1,000 | -90.0% | 134 | -76.7% | 0.00% | – |
| Q4 2015 | $10,000 | -91.5% | 574 | -91.2% | 0.00% | – |
| Q3 2015 | $117,000 | +2240.0% | 6,547 | +1587.4% | 0.00% | – |
| Q2 2015 | $5,000 | +150.0% | 388 | +158.7% | 0.00% | – |
| Q1 2015 | $2,000 | +100.0% | 150 | +108.3% | 0.00% | – |
| Q3 2014 | $1,000 | -99.5% | 72 | -99.6% | 0.00% | – |
| Q2 2014 | $205,000 | +166.2% | 20,513 | +243.5% | 0.00% | – |
| Q1 2014 | $77,000 | – | 5,971 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 4,420,349 | $25,814,838 | 3.96% |
| Parkman Healthcare Partners LLC | 1,203,484 | $7,028,347 | 1.87% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,002,783 | $5,856,253 | 1.26% |
| TANG CAPITAL MANAGEMENT LLC | 1,150,000 | $6,716,000 | 0.98% |
| BVF INC/IL | 3,629,000 | $21,193,360 | 0.89% |
| Nantahala Capital Management | 1,732,388 | $10,117,146 | 0.66% |
| AWM Investment Company, Inc. | 666,661 | $3,893,300 | 0.56% |
| INGALLS & SNYDER LLC | 1,295,833 | $7,568 | 0.41% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 200,800 | $1,172,672 | 0.36% |
| Kensington Investment Counsel, LLC | 58,599 | $342,218 | 0.27% |